Great Point Partners LLC Alnylam Pharmaceuticals, Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 14, 2019
SELL
$72.76 - $93.45 $2.92 Million - $3.76 Million
-40,197 Closed
0 $0
Q4 2018

Feb 15, 2019
SELL
$62.67 - $88.33 $16.3 Million - $22.9 Million
-259,803 Reduced 86.6%
40,197 $2.93 Million
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $3.49 Million - $4.89 Million
39,900 Added 15.34%
300,000 $26.3 Million
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $23 Million - $28 Million
260,100 New
260,100 $25.6 Million

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email